FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$17.18|
|52 Week High||US$16.51|
|52 Week Low||US$23.99|
|1 Month Change||3.37%|
|3 Month Change||-0.23%|
|1 Year Change||-23.24%|
|3 Year Change||-30.59%|
|5 Year Change||-16.24%|
|Change since IPO||4.72%|
Recent News & Updates
|FONR||US Medical Equipment||US Market|
Return vs Industry: FONR underperformed the US Medical Equipment industry which returned 34.7% over the past year.
Return vs Market: FONR underperformed the US Market which returned 31.5% over the past year.
Stable Share Price: FONR is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: FONR's weekly volatility (3%) has been stable over the past year.
About the Company
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.
FONAR Fundamentals Summary
|FONR fundamental statistics|
Is FONR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|FONR income statement (TTM)|
|Cost of Revenue||US$42.73m|
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
|Earnings per share (EPS)||1.42|
|Net Profit Margin||11.17%|
How did FONR perform over the long term?See historical performance and comparison
Is FONAR undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: FONR ($17.18) is trading below our estimate of fair value ($41.53)
Significantly Below Fair Value: FONR is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: FONR is good value based on its PE Ratio (11.9x) compared to the US Medical Equipment industry average (50.5x).
PE vs Market: FONR is good value based on its PE Ratio (11.9x) compared to the US market (17.5x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate FONR's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: FONR is good value based on its PB Ratio (0.8x) compared to the US Medical Equipment industry average (4.7x).
How is FONAR forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as FONAR has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has FONAR performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: FONR has high quality earnings.
Growing Profit Margin: FONR's current net profit margins (11.2%) are lower than last year (13.4%).
Past Earnings Growth Analysis
Earnings Trend: FONR's earnings have declined by 11.5% per year over the past 5 years.
Accelerating Growth: FONR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: FONR had negative earnings growth (-17.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (40.5%).
Return on Equity
High ROE: FONR's Return on Equity (9.3%) is considered low.
How is FONAR's financial position?
Financial Position Analysis
Short Term Liabilities: FONR's short term assets ($103.6M) exceed its short term liabilities ($17.1M).
Long Term Liabilities: FONR's short term assets ($103.6M) exceed its long term liabilities ($33.4M).
Debt to Equity History and Analysis
Debt Level: FONR's debt to equity ratio (0.7%) is considered satisfactory.
Reducing Debt: FONR's debt to equity ratio has reduced from 10.8% to 0.7% over the past 5 years.
Debt Coverage: FONR's debt is well covered by operating cash flow (2036.4%).
Interest Coverage: FONR earns more interest than it pays, so coverage of interest payments is not a concern.
What is FONAR current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate FONR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate FONR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if FONR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if FONR's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of FONR's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tim Damadian (57 yo)
Mr. Timothy R. Damadian, also known as Tim, has been Chief Executive Officer and President of Fonar Corp. since February 11, 2016. From 2010 to 2016 he served as an independent consultant. Mr. Damadian beg...
Experienced Management: FONR's management team is seasoned and experienced (5.6 years average tenure).
Experienced Board: FONR's board of directors are seasoned and experienced ( 21.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
FONAR Corporation's employee growth, exchange listings and data sources
- Name: FONAR Corporation
- Ticker: FONR
- Exchange: NasdaqCM
- Founded: 1978
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$114.794m
- Shares outstanding: 6.68m
- Website: https://www.fonar.com
Number of Employees
- FONAR Corporation
- 110 Marcus Drive
- New York
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/22 22:32|
|End of Day Share Price||2021/09/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.